In a BCR-ABL dose-dependent manner miR-328 goes down during blast crisis in CML, and its restoration rescues cellular differentiation and affects the survival of leukemic blast [173]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.